AtriCure, Inc. (ATRC)
39.72
+0.78
(+2.00%)
USD |
NASDAQ |
Dec 09, 16:00
39.71
-0.01
(-0.03%)
After-Hours: 20:00
AtriCure EPS Diluted (Quarterly): -0.0056 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.9146 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Catheter Precision, Inc. | -1.705 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.267M |
| Revenue (Quarterly) | 134.27M |
| Total Expenses (Quarterly) | 134.54M |
| Enterprise Value | 1.910B |
| Gross Profit Margin (Quarterly) | 74.90% |
| Profit Margin (Quarterly) | -0.20% |
| Earnings Yield | -1.53% |
| Normalized Earnings Yield | -0.8975 |